In 2023, France led the European environmentally related tax revenue from pollution in pharmaceutical manufacturing at 41.63 million USD, followed by the Netherlands and the UK. Notable increases were observed in Ireland and the Czech Republic, with Ireland experiencing a significant surge of over 33%. France and Switzerland showed moderate growth, while the Netherlands and the UK reported declining revenues. The 5-year CAGR highlights diverse regional trends, reflecting variable environmental strategies and market dynamics.
Future trends to monitor include shifts in regulatory frameworks and sustainable practices, which may influence tax revenue streams. Increased focus on green manufacturing processes could lead to lower pollution-related taxes. Additionally, disparities in regional policies may affect competitive dynamics across countries.
Top countries in Environmentally Related Tax Revenue from Taxes on Pollution in Manufacturing of Basic Pharmaceutical Products and Pharmaceutical Preparations Share by Country (Million US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 France | 41.63 | 2023 | +0.57% | +2.05% | View data |
| 2 | 2 Netherlands | 24.32 | 2023 | +0.47% | -5.92% | View data |
| 3 | 3 United Kingdom | 15.12 | 2023 | -9.82% | -8.5% | View data |
| 4 | 4 Switzerland | 5.03 | 2023 | +0.55% | +2.56% | View data |
| 5 | 5 Poland | 4.77 | 2023 | -2.62% | -1.95% | View data |
| 6 | 6 Belgium | 4.44 | 2023 | -1.97% | -1.82% | View data |
| 7 | 7 Hungary | 3.9 | 2023 | +3.08% | +3.23% | View data |
| 8 | 8 Ireland | 2.76 | 2023 | +16.59% | +33.16% | View data |
| 9 | 9 Czech Republic | 0.99 | 2023 | +4.21% | +15.39% | View data |
| 10 | 10 Sweden | 0.76 | 2023 | +6.67% | +5.71% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
